|
muscle system process
|
GO:0003012 |
141 |
0.908
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.895
|
|
|
regulation of muscle system process
|
GO:0090257 |
80 |
0.831
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.798
|
|
|
muscle cell development
|
GO:0055001 |
133 |
0.783
|
|
|
heart contraction
|
GO:0060047 |
93 |
0.606
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.600
|
|
|
cardiac muscle cell development
|
GO:0055013 |
39 |
0.513
|
|
|
cardiac muscle tissue development
|
GO:0048738 |
130 |
0.481
|
|
|
cardiocyte differentiation
|
GO:0035051 |
87 |
0.464
|
|
|
cellular component assembly involved in morphogenesis
|
GO:0010927 |
139 |
0.462
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.451
|
|
|
regulation of blood circulation
|
GO:1903522 |
93 |
0.431
|
|
|
striated muscle cell development
|
GO:0055002 |
125 |
0.425
|
|
|
sarcomere organization
|
GO:0045214 |
24 |
0.408
|
|
|
organelle assembly
|
GO:0070925 |
177 |
0.397
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.377
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.368
|
|
|
muscle adaptation
|
GO:0043500 |
39 |
0.364
|
|
|
organ growth
|
GO:0035265 |
117 |
0.359
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.350
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.335
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.312
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.288
|
|
|
muscle contraction
|
GO:0006936 |
101 |
0.274
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.274
|
|
|
regulation of blood pressure
|
GO:0008217 |
93 |
0.266
|
|
|
heart process
|
GO:0003015 |
94 |
0.258
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.257
|
|
|
striated muscle contraction
|
GO:0006941 |
45 |
0.255
|
|
|
regulation of heart contraction
|
GO:0008016 |
77 |
0.233
|
|
|
lipid transport
|
GO:0006869 |
98 |
0.197
|
|
|
cation transport
|
GO:0006812 |
399 |
0.194
|
|
|
inorganic ion transmembrane transport
|
GO:0098660 |
234 |
0.187
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.185
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.183
|
Rat |
|
cation homeostasis
|
GO:0055080 |
212 |
0.182
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.178
|
|
|
muscle fiber development
|
GO:0048747 |
76 |
0.172
|
|
|
regulation of feeding behavior
|
GO:0060259 |
3 |
0.170
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.169
|
|
|
renal system process
|
GO:0003014 |
48 |
0.166
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.164
|
|
|
cardiac muscle contraction
|
GO:0060048 |
32 |
0.162
|
|
|
cardiac cell development
|
GO:0055006 |
41 |
0.160
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.156
|
|
|
myotube differentiation
|
GO:0014902 |
105 |
0.152
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.144
|
|
|
regulation of muscle adaptation
|
GO:0043502 |
31 |
0.143
|
|
|
regulation of ion transport
|
GO:0043269 |
215 |
0.139
|
|
|
regulation of vasculature development
|
GO:1901342 |
88 |
0.138
|
|
|
potassium ion transmembrane transport
|
GO:0071805 |
43 |
0.136
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.134
|
|
|
bone development
|
GO:0060348 |
120 |
0.129
|
|
|
ventricular cardiac myofibril assembly
|
GO:0055005 |
3 |
0.129
|
|
|
cardiac muscle cell differentiation
|
GO:0055007 |
69 |
0.128
|
|
|
striated muscle adaptation
|
GO:0014888 |
26 |
0.125
|
|
|
cation transmembrane transport
|
GO:0098655 |
266 |
0.122
|
|
|
cardiac muscle tissue morphogenesis
|
GO:0055008 |
44 |
0.120
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.119
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.118
|
|
|
muscle cell proliferation
|
GO:0033002 |
52 |
0.117
|
|
|
actomyosin structure organization
|
GO:0031032 |
56 |
0.115
|
|
|
regulation of tube size
|
GO:0035150 |
57 |
0.115
|
|
|
ossification
|
GO:0001503 |
216 |
0.112
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.111
|
|
|
small molecule biosynthetic process
|
GO:0044283 |
132 |
0.111
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.109
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.109
|
Rat |
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.108
|
|
|
skeletal muscle fiber development
|
GO:0048741 |
58 |
0.102
|
|
|
connective tissue development
|
GO:0061448 |
179 |
0.102
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
164 |
0.100
|
|
|
striated muscle hypertrophy
|
GO:0014897 |
24 |
0.100
|
|
|
heart growth
|
GO:0060419 |
45 |
0.100
|
|
|
regulation of heart rate
|
GO:0002027 |
36 |
0.099
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.098
|
Rat |
|
regulation of organ growth
|
GO:0046620 |
61 |
0.098
|
|
|
positive regulation of secretion
|
GO:0051047 |
130 |
0.098
|
|
|
fatty acid metabolic process
|
GO:0006631 |
121 |
0.096
|
|
|
regulation of heart growth
|
GO:0060420 |
31 |
0.096
|
|
|
muscle tissue morphogenesis
|
GO:0060415 |
53 |
0.095
|
|
|
chondrocyte differentiation
|
GO:0002062 |
72 |
0.095
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.095
|
|
|
regulation of neurotransmitter levels
|
GO:0001505 |
87 |
0.093
|
|
|
regulation of muscle contraction
|
GO:0006937 |
49 |
0.092
|
|
|
regulation of cardiac muscle tissue development
|
GO:0055024 |
31 |
0.092
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.092
|
|
|
inorganic cation transmembrane transport
|
GO:0098662 |
207 |
0.091
|
|
|
lipid biosynthetic process
|
GO:0008610 |
179 |
0.090
|
|
|
myosin filament organization
|
GO:0031033 |
3 |
0.090
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.090
|
|
|
lung development
|
GO:0030324 |
164 |
0.089
|
|
|
cardiac muscle hypertrophy
|
GO:0003300 |
23 |
0.089
|
|
|
positive regulation of neuron differentiation
|
GO:0045666 |
141 |
0.087
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.087
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.087
|
|
|
multi organism behavior
|
GO:0051705 |
62 |
0.083
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.083
|
|
|
cardiac myofibril assembly
|
GO:0055003 |
12 |
0.082
|
|
|
regulation of muscle tissue development
|
GO:1901861 |
97 |
0.082
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.082
|
|
|
regulation of ossification
|
GO:0030278 |
112 |
0.082
|
|
|
smooth muscle contraction
|
GO:0006939 |
44 |
0.081
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.079
|
|
|
negative regulation of neuron differentiation
|
GO:0045665 |
101 |
0.079
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.078
|
Rat |
|
muscle hypertrophy
|
GO:0014896 |
24 |
0.077
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.077
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.076
|
Rat |
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.075
|
Rat |
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.074
|
|
|
regulation of ion transmembrane transport
|
GO:0034765 |
119 |
0.073
|
|
|
cardiac chamber development
|
GO:0003205 |
108 |
0.073
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.071
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.070
|
|
|
cellular calcium ion homeostasis
|
GO:0006874 |
119 |
0.067
|
|
|
myofibril assembly
|
GO:0030239 |
34 |
0.064
|
|
|
tube closure
|
GO:0060606 |
91 |
0.064
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
1 |
0.064
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.063
|
|
|
vasoconstriction
|
GO:0042310 |
27 |
0.063
|
|
|
regulation of systemic arterial blood pressure
|
GO:0003073 |
61 |
0.063
|
Rat |
|
neural crest cell migration
|
GO:0001755 |
32 |
0.063
|
|
|
endochondral bone morphogenesis
|
GO:0060350 |
50 |
0.062
|
|
|
feeding behavior
|
GO:0007631 |
62 |
0.062
|
|
|
regulation of striated muscle cell differentiation
|
GO:0051153 |
81 |
0.062
|
|
|
regulation of transporter activity
|
GO:0032409 |
57 |
0.062
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.061
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.061
|
|
|
neurotransmitter transport
|
GO:0006836 |
76 |
0.061
|
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.061
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.060
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
0 |
0.059
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.058
|
|
|
epithelial tube formation
|
GO:0072175 |
130 |
0.058
|
|
|
bone morphogenesis
|
GO:0060349 |
78 |
0.057
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.057
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.055
|
|
|
regulation of inflammatory response
|
GO:0050727 |
147 |
0.055
|
|
|
cellular metal ion homeostasis
|
GO:0006875 |
151 |
0.055
|
|
|
intracellular receptor signaling pathway
|
GO:0030522 |
74 |
0.054
|
|
|
regulation of reproductive process
|
GO:2000241 |
66 |
0.054
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.054
|
|
|
skeletal muscle thin filament assembly
|
GO:0030240 |
2 |
0.054
|
|
|
neurotransmitter secretion
|
GO:0007269 |
62 |
0.054
|
|
|
primary neural tube formation
|
GO:0014020 |
95 |
0.053
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.053
|
|
|
tendon cell differentiation
|
GO:0035990 |
4 |
0.053
|
|
|
cardiac chamber morphogenesis
|
GO:0003206 |
93 |
0.052
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.052
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.052
|
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.052
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.052
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.051
|
|
|
adenylate cyclase inhibiting g protein coupled receptor signaling pathway
|
GO:0007193 |
20 |
0.051
|
|
|
cartilage development
|
GO:0051216 |
140 |
0.051
|
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
191 |
0.051
|
|
|
bmp signaling pathway
|
GO:0030509 |
93 |
0.051
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.051
|
|
|
organic acid biosynthetic process
|
GO:0016053 |
86 |
0.050
|
|
|
cardiac muscle hypertrophy in response to stress
|
GO:0014898 |
10 |
0.050
|
|
|
regulation of circadian rhythm
|
GO:0042752 |
58 |
0.050
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.049
|
|
|
cellular potassium ion transport
|
GO:0071804 |
43 |
0.049
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.049
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.048
|
Rat |
|
regulation of neuron projection development
|
GO:0010975 |
169 |
0.048
|
|
|
forelimb morphogenesis
|
GO:0035136 |
40 |
0.048
|
|
|
multi multicellular organism process
|
GO:0044706 |
109 |
0.048
|
|
|
positive regulation of cell motility
|
GO:2000147 |
116 |
0.047
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.047
|
|
|
extracellular structure organization
|
GO:0043062 |
148 |
0.047
|
|
|
calcium mediated signaling
|
GO:0019722 |
46 |
0.047
|
|
|
response to organophosphorus
|
GO:0046683 |
22 |
0.047
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.046
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.046
|
|
|
extracellular matrix organization
|
GO:0030198 |
147 |
0.046
|
|
|
regulation of lymphocyte proliferation
|
GO:0050670 |
117 |
0.046
|
|
|
response to alkaloid
|
GO:0043279 |
34 |
0.045
|
|
|
renal system development
|
GO:0072001 |
225 |
0.045
|
|
|
regulation of ion transmembrane transporter activity
|
GO:0032412 |
54 |
0.045
|
|
|
rhythmic process
|
GO:0048511 |
174 |
0.045
|
|
|
endothelial cell differentiation
|
GO:0045446 |
41 |
0.045
|
|
|
cell growth
|
GO:0016049 |
130 |
0.044
|
Rat |
|
biomineral tissue development
|
GO:0031214 |
64 |
0.044
|
|
|
lymphocyte proliferation
|
GO:0046651 |
164 |
0.044
|
|
|
tube formation
|
GO:0035148 |
140 |
0.044
|
|
|
positive regulation of growth
|
GO:0045927 |
104 |
0.044
|
|
|
negative regulation of ossification
|
GO:0030279 |
49 |
0.044
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.044
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.043
|
|
|
aortic valve morphogenesis
|
GO:0003180 |
4 |
0.043
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.043
|
|
|
regulation of the force of heart contraction
|
GO:0002026 |
17 |
0.042
|
|
|
second messenger mediated signaling
|
GO:0019932 |
73 |
0.042
|
|
|
endomembrane system organization
|
GO:0010256 |
147 |
0.042
|
|
|
membrane depolarization
|
GO:0051899 |
64 |
0.042
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
159 |
0.042
|
|
|
regulation of actin filament based process
|
GO:0032970 |
99 |
0.042
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.042
|
|
|
kidney epithelium development
|
GO:0072073 |
121 |
0.042
|
|
|
regulation of b cell activation
|
GO:0050864 |
81 |
0.041
|
|
|
positive regulation of camp mediated signaling
|
GO:0043950 |
3 |
0.041
|
|
|
regulation of angiogenesis
|
GO:0045765 |
81 |
0.041
|
|
|
chromatin modification
|
GO:0016568 |
187 |
0.041
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.041
|
|
|
regulation of multicellular organismal metabolic process
|
GO:0044246 |
14 |
0.041
|
|
|
astrocyte fate commitment
|
GO:0060018 |
4 |
0.041
|
|
|
kidney morphogenesis
|
GO:0060993 |
83 |
0.041
|
|
|
response to oxygen levels
|
GO:0070482 |
62 |
0.041
|
Rat |
|
regulation of metal ion transport
|
GO:0010959 |
106 |
0.040
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.040
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.040
|
|
|
neural tube development
|
GO:0021915 |
160 |
0.040
|
|
|
sodium ion homeostasis
|
GO:0055078 |
7 |
0.040
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.040
|
|
|
neural tube formation
|
GO:0001841 |
108 |
0.039
|
|
|
multicellular organismal response to stress
|
GO:0033555 |
62 |
0.039
|
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.039
|
|
|
vascular process in circulatory system
|
GO:0003018 |
62 |
0.039
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.038
|
|
|
negative regulation of cytokine production
|
GO:0001818 |
84 |
0.038
|
|
|
regulation of neuron death
|
GO:1901214 |
134 |
0.038
|
|
|
directional locomotion
|
GO:0033058 |
3 |
0.038
|
|
|
calcium ion homeostasis
|
GO:0055074 |
127 |
0.038
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.037
|
|
|
positive regulation of synaptic plasticity
|
GO:0031915 |
4 |
0.037
|
|
|
regulation of peptidyl serine phosphorylation
|
GO:0033135 |
39 |
0.037
|
|
|
phospholipase c activating g protein coupled receptor signaling pathway
|
GO:0007200 |
26 |
0.037
|
|
|
regionalization
|
GO:0003002 |
337 |
0.037
|
|
|
axon guidance
|
GO:0007411 |
141 |
0.037
|
|
|
embryonic limb morphogenesis
|
GO:0030326 |
126 |
0.037
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.036
|
|
|
regulation of cell cycle process
|
GO:0010564 |
160 |
0.036
|
|
|
embryonic epithelial tube formation
|
GO:0001838 |
130 |
0.035
|
|
|
fear response
|
GO:0042596 |
33 |
0.035
|
|
|
lipid localization
|
GO:0010876 |
126 |
0.035
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.035
|
|
|
cardiac muscle cell contraction
|
GO:0086003 |
7 |
0.034
|
|
|
actin filament based movement
|
GO:0030048 |
23 |
0.034
|
|
|
mesodermal cell migration
|
GO:0008078 |
4 |
0.034
|
|
|
cell substrate adhesion
|
GO:0031589 |
130 |
0.034
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.034
|
|
|
adenylate cyclase modulating g protein coupled receptor signaling pathway
|
GO:0007188 |
54 |
0.034
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.034
|
|
|
tissue remodeling
|
GO:0048771 |
102 |
0.034
|
|
|
erythrocyte differentiation
|
GO:0030218 |
88 |
0.034
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.034
|
Rat |
|
response to purine containing compound
|
GO:0014074 |
28 |
0.033
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.033
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.033
|
|
|
regulation of leukocyte proliferation
|
GO:0070663 |
121 |
0.033
|
|
|
cell proliferation involved in outflow tract morphogenesis
|
GO:0061325 |
4 |
0.033
|
|
|
rna processing
|
GO:0006396 |
105 |
0.033
|
|
|
negative regulation of ion transport
|
GO:0043271 |
28 |
0.033
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.033
|
|
|
positive regulation of potassium ion transmembrane transport
|
GO:1901381 |
3 |
0.033
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.032
|
|
|
cellular ion homeostasis
|
GO:0006873 |
165 |
0.032
|
|
|
limb development
|
GO:0060173 |
166 |
0.032
|
|
|
alcohol metabolic process
|
GO:0006066 |
116 |
0.032
|
|
|
response to oxidative stress
|
GO:0006979 |
123 |
0.032
|
|
|
spinal cord development
|
GO:0021510 |
81 |
0.032
|
|
|
regulation of excretion
|
GO:0044062 |
5 |
0.032
|
|
|
covalent chromatin modification
|
GO:0016569 |
163 |
0.032
|
|
|
tendon formation
|
GO:0035992 |
4 |
0.032
|
|
|
divalent metal ion transport
|
GO:0070838 |
172 |
0.031
|
|
|
atrial cardiac muscle cell development
|
GO:0055014 |
2 |
0.031
|
|
|
regulation of ion homeostasis
|
GO:2000021 |
64 |
0.031
|
|
|
response to extracellular stimulus
|
GO:0009991 |
127 |
0.031
|
|
|
sodium ion transmembrane transport
|
GO:0035725 |
49 |
0.031
|
|
|
t cell proliferation
|
GO:0042098 |
120 |
0.031
|
|
|
water homeostasis
|
GO:0030104 |
27 |
0.031
|
|
|
organic anion transport
|
GO:0015711 |
137 |
0.031
|
|
|
embryonic heart tube morphogenesis
|
GO:0003143 |
51 |
0.031
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.030
|
|
|
regulation of transmembrane transport
|
GO:0034762 |
128 |
0.030
|
|
|
potassium ion transport
|
GO:0006813 |
52 |
0.030
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.030
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.030
|
|
|
positive regulation of neuron projection development
|
GO:0010976 |
79 |
0.030
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.030
|
|
|
neuron projection guidance
|
GO:0097485 |
141 |
0.029
|
|
|
response to reactive oxygen species
|
GO:0000302 |
56 |
0.029
|
|
|
ameboidal type cell migration
|
GO:0001667 |
128 |
0.029
|
|
|
positive regulation of cell projection organization
|
GO:0031346 |
95 |
0.029
|
|
|
female gamete generation
|
GO:0007292 |
74 |
0.029
|
|
|
skeletal muscle cell differentiation
|
GO:0035914 |
66 |
0.029
|
|
|
acetylcholine secretion neurotransmission
|
GO:0014055 |
2 |
0.028
|
|
|
multicellular organismal metabolic process
|
GO:0044236 |
28 |
0.028
|
|
|
tissue homeostasis
|
GO:0001894 |
115 |
0.028
|
|
|
positive regulation of blood circulation
|
GO:1903524 |
22 |
0.028
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.028
|
|
|
acetate ester transport
|
GO:1901374 |
2 |
0.028
|
|
|
response to monosaccharide
|
GO:0034284 |
67 |
0.028
|
|
|
renal water homeostasis
|
GO:0003091 |
7 |
0.027
|
|
|
ventricular cardiac muscle cell differentiation
|
GO:0055012 |
17 |
0.027
|
|
|
spermatid differentiation
|
GO:0048515 |
115 |
0.027
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.027
|
|
|
cardiac muscle fiber development
|
GO:0048739 |
4 |
0.027
|
|
|
monocarboxylic acid transport
|
GO:0015718 |
44 |
0.027
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.027
|
|
|
regulation of excitatory postsynaptic membrane potential
|
GO:0060079 |
41 |
0.027
|
|
|
cell fate commitment
|
GO:0045165 |
210 |
0.027
|
|
|
transition between fast and slow fiber
|
GO:0014883 |
9 |
0.027
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.027
|
|
|
cell proliferation in hindbrain
|
GO:0021534 |
10 |
0.027
|
|
|
locomotory behavior
|
GO:0007626 |
195 |
0.027
|
|
|
endocardial cushion to mesenchymal transition involved in heart valve formation
|
GO:0003199 |
4 |
0.027
|
|
|
regulation of renal sodium excretion
|
GO:0035813 |
3 |
0.026
|
|
|
renal sodium excretion
|
GO:0035812 |
3 |
0.026
|
|
|
collagen biosynthetic process
|
GO:0032964 |
7 |
0.026
|
|
|
divalent inorganic cation homeostasis
|
GO:0072507 |
138 |
0.026
|
|
|
cell proliferation involved in heart valve development
|
GO:2000793 |
2 |
0.026
|
|
|
endodermal cell fate specification
|
GO:0001714 |
4 |
0.026
|
|
|
mesoderm morphogenesis
|
GO:0048332 |
64 |
0.026
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.026
|
|
|
tissue migration
|
GO:0090130 |
68 |
0.026
|
|
|
negative regulation of nervous system development
|
GO:0051961 |
156 |
0.026
|
|
|
adenylate cyclase activating g protein coupled receptor signaling pathway
|
GO:0007189 |
30 |
0.026
|
|
|
cardiac muscle tissue growth
|
GO:0055017 |
37 |
0.026
|
|
|
protein acylation
|
GO:0043543 |
64 |
0.026
|
|
|
somatotropin secreting cell differentiation
|
GO:0060126 |
4 |
0.025
|
|
|
nephron development
|
GO:0072006 |
109 |
0.025
|
|
|
guanosine containing compound metabolic process
|
GO:1901068 |
144 |
0.025
|
|
|
organic hydroxy compound biosynthetic process
|
GO:1901617 |
77 |
0.025
|
|
|
gtp metabolic process
|
GO:0046039 |
144 |
0.025
|
|
|
bone mineralization
|
GO:0030282 |
54 |
0.025
|
|
|
developmental growth involved in morphogenesis
|
GO:0060560 |
138 |
0.025
|
|
|
positive regulation of cardiac muscle tissue growth
|
GO:0055023 |
15 |
0.025
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.025
|
|
|
unsaturated fatty acid metabolic process
|
GO:0033559 |
31 |
0.025
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.025
|
|
|
carbohydrate transport
|
GO:0008643 |
62 |
0.025
|
|
|
embryonic skeletal system development
|
GO:0048706 |
120 |
0.025
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.025
|
|
|
neural tube closure
|
GO:0001843 |
90 |
0.025
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.025
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.025
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.025
|
|
|
positive regulation of ion transport
|
GO:0043270 |
65 |
0.025
|
|
|
myoblast differentiation
|
GO:0045445 |
52 |
0.024
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.024
|
|
|
glycoprotein metabolic process
|
GO:0009100 |
116 |
0.024
|
|
|
response to nutrient levels
|
GO:0031667 |
109 |
0.024
|
|
|
response to hypoxia
|
GO:0001666 |
58 |
0.024
|
Rat |
|
ribose phosphate biosynthetic process
|
GO:0046390 |
59 |
0.024
|
Rat |
|
regulation of myeloid cell differentiation
|
GO:0045637 |
96 |
0.024
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.024
|
|
|
formation of primary germ layer
|
GO:0001704 |
77 |
0.024
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.024
|
|
|
positive regulation of lymphocyte proliferation
|
GO:0050671 |
70 |
0.024
|
|
|
histone modification
|
GO:0016570 |
159 |
0.024
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.023
|
|
|
glycerolipid metabolic process
|
GO:0046486 |
122 |
0.023
|
|
|
cardiac ventricle morphogenesis
|
GO:0003208 |
50 |
0.023
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.023
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.023
|
|
|
myotube cell development
|
GO:0014904 |
60 |
0.023
|
|
|
release of sequestered calcium ion into cytosol
|
GO:0051209 |
42 |
0.023
|
|
|
cellular response to transforming growth factor beta stimulus
|
GO:0071560 |
88 |
0.023
|
|
|
leukocyte migration
|
GO:0050900 |
124 |
0.023
|
|
|
leukocyte proliferation
|
GO:0070661 |
172 |
0.023
|
|
|
defense response to other organism
|
GO:0098542 |
197 |
0.023
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
206 |
0.023
|
|
|
actin filament organization
|
GO:0007015 |
113 |
0.022
|
|
|
organelle localization
|
GO:0051640 |
179 |
0.022
|
|
|
response to lipopolysaccharide
|
GO:0032496 |
128 |
0.022
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.022
|
|
|
conditioned taste aversion
|
GO:0001661 |
4 |
0.022
|
|
|
regulation of purine nucleotide catabolic process
|
GO:0033121 |
122 |
0.022
|
|
|
cellular lipid catabolic process
|
GO:0044242 |
52 |
0.022
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.022
|
|
|
fatty acid derivative metabolic process
|
GO:1901568 |
33 |
0.022
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.022
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.022
|
|
|
regulation of steroid metabolic process
|
GO:0019218 |
39 |
0.022
|
|
|
wound healing
|
GO:0042060 |
157 |
0.022
|
|
|
immunoglobulin production
|
GO:0002377 |
73 |
0.022
|
|
|
cell maturation
|
GO:0048469 |
127 |
0.022
|
|
|
blood vessel remodeling
|
GO:0001974 |
33 |
0.022
|
|
|
stem cell proliferation
|
GO:0072089 |
117 |
0.022
|
|
|
inter male aggressive behavior
|
GO:0002121 |
3 |
0.022
|
|
|
nephron epithelium development
|
GO:0072009 |
92 |
0.022
|
|
|
mitral valve development
|
GO:0003174 |
4 |
0.022
|
|
|
organic acid transport
|
GO:0015849 |
101 |
0.021
|
|
|
positive regulation of secretion by cell
|
GO:1903532 |
114 |
0.021
|
|
|
regulation of blood vessel size
|
GO:0050880 |
56 |
0.021
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.021
|
|
|
regulation of stem cell differentiation
|
GO:2000736 |
50 |
0.021
|
|
|
somatic cell dna recombination
|
GO:0016444 |
51 |
0.021
|
|
|
glucose homeostasis
|
GO:0042593 |
128 |
0.021
|
|
|
negative regulation of synapse assembly
|
GO:0051964 |
3 |
0.021
|
|
|
icosanoid metabolic process
|
GO:0006690 |
33 |
0.021
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.021
|
|
|
sequestering of calcium ion
|
GO:0051208 |
18 |
0.021
|
|
|
regulation of endocardial cushion to mesenchymal transition involved in heart valve formation
|
GO:2000800 |
1 |
0.021
|
|
|
epithelial cell migration
|
GO:0010631 |
63 |
0.021
|
|
|
mesendoderm development
|
GO:0048382 |
3 |
0.021
|
|
|
reactive oxygen species biosynthetic process
|
GO:1903409 |
8 |
0.021
|
|
|
nephrogenic mesenchyme development
|
GO:0072076 |
3 |
0.021
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.021
|
|
|
negative regulation of cell growth
|
GO:0030308 |
44 |
0.021
|
Rat |
|
ventricular cardiac muscle tissue development
|
GO:0003229 |
38 |
0.021
|
|
|
central nervous system neuron differentiation
|
GO:0021953 |
162 |
0.020
|
|
|
regulation of lipid biosynthetic process
|
GO:0046890 |
54 |
0.020
|
|
|
positive regulation of potassium ion transport
|
GO:0043268 |
3 |
0.020
|
|
|
regulation of retina development in camera type eye
|
GO:1902866 |
3 |
0.020
|
|
|
regulation of intestinal epithelial structure maintenance
|
GO:0060730 |
1 |
0.020
|
|
|
multicellular organismal macromolecule metabolic process
|
GO:0044259 |
19 |
0.020
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.020
|
|
|
planar cell polarity pathway involved in pericardium morphogenesis
|
GO:0061354 |
2 |
0.020
|
|
|
organic acid catabolic process
|
GO:0016054 |
51 |
0.020
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.020
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.020
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.020
|
|
|
positive regulation of secondary heart field cardioblast proliferation
|
GO:0072513 |
4 |
0.020
|
|
|
monocarboxylic acid catabolic process
|
GO:0072329 |
27 |
0.020
|
|
|
negative regulation of cell projection organization
|
GO:0031345 |
56 |
0.020
|
|
|
regulation of nucleotide catabolic process
|
GO:0030811 |
122 |
0.020
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.020
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.020
|
|
|
multicellular organismal signaling
|
GO:0035637 |
91 |
0.020
|
|
|
positive regulation of protein transport
|
GO:0051222 |
93 |
0.020
|
|
|
regulation of striated muscle contraction
|
GO:0006942 |
25 |
0.020
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.020
|
|
|
hormone metabolic process
|
GO:0042445 |
86 |
0.020
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.020
|
|
|
gas homeostasis
|
GO:0033483 |
3 |
0.020
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.020
|
|
|
long chain fatty acid metabolic process
|
GO:0001676 |
26 |
0.020
|
|
|
positive regulation of glycolytic process
|
GO:0045821 |
4 |
0.020
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.020
|
Rat |
|
positive regulation of mesenchymal cell proliferation involved in ureter development
|
GO:2000729 |
3 |
0.020
|
|
|
dendrite development
|
GO:0016358 |
115 |
0.020
|
|
|
positive regulation of organ growth
|
GO:0046622 |
29 |
0.020
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.019
|
|
|
positive regulation of striated muscle tissue development
|
GO:0045844 |
31 |
0.019
|
|
|
regulation of postsynaptic membrane potential
|
GO:0060078 |
48 |
0.019
|
|
|
negative regulation of cell migration
|
GO:0030336 |
59 |
0.019
|
|
|
response to decreased oxygen levels
|
GO:0036293 |
59 |
0.019
|
Rat |
|
positive regulation of hydrolase activity
|
GO:0051345 |
148 |
0.019
|
|
|
spermatid development
|
GO:0007286 |
108 |
0.019
|
|
|
negative regulation of transmembrane transport
|
GO:0034763 |
15 |
0.019
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.019
|
|
|
regulation of lipid metabolic process
|
GO:0019216 |
118 |
0.019
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.019
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
84 |
0.019
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.019
|
|
|
regulation of interferon gamma production
|
GO:0032649 |
57 |
0.019
|
|
|
planar cell polarity pathway involved in ventricular septum morphogenesis
|
GO:0061348 |
2 |
0.019
|
|
|
alpha beta t cell differentiation
|
GO:0046632 |
69 |
0.019
|
|
|
transdifferentiation
|
GO:0060290 |
1 |
0.019
|
|
|
mesoderm development
|
GO:0007498 |
100 |
0.019
|
|
|
regulation of protein transport
|
GO:0051223 |
163 |
0.019
|
|
|
positive regulation of endocardial cushion to mesenchymal transition involved in heart valve formation
|
GO:2000802 |
1 |
0.019
|
|
|
regulation of chemotaxis
|
GO:0050920 |
53 |
0.019
|
|
|
fatty acid biosynthetic process
|
GO:0006633 |
41 |
0.018
|
|
|
synapse organization
|
GO:0050808 |
125 |
0.018
|
|
|
regulation of body fluid levels
|
GO:0050878 |
162 |
0.018
|
|
|
collagen fibril organization
|
GO:0030199 |
32 |
0.018
|
|
|
interleukin 8 production
|
GO:0032637 |
4 |
0.018
|
|
|
response to pain
|
GO:0048265 |
26 |
0.018
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.018
|
|
|
regulation of myotube differentiation
|
GO:0010830 |
62 |
0.018
|
|
|
negative regulation of neuron projection development
|
GO:0010977 |
50 |
0.018
|
|
|
embryonic eye morphogenesis
|
GO:0048048 |
29 |
0.018
|
|
|
canonical wnt signaling pathway involved in regulation of cell proliferation
|
GO:0044340 |
3 |
0.018
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.018
|
Rat |
|
positive regulation of renal sodium excretion
|
GO:0035815 |
2 |
0.018
|
|
|
vagus nerve development
|
GO:0021564 |
3 |
0.018
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.018
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.018
|
|
|
steroid metabolic process
|
GO:0008202 |
119 |
0.018
|
|
|
striated muscle cell proliferation
|
GO:0014855 |
39 |
0.018
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.018
|
|
|
regulation of cell morphogenesis involved in differentiation
|
GO:0010769 |
151 |
0.018
|
|
|
regulation of stem cell proliferation
|
GO:0072091 |
78 |
0.018
|
|
|
neuron death
|
GO:0070997 |
154 |
0.018
|
|
|
regulation of multi organism process
|
GO:0043900 |
111 |
0.018
|
|
|
regulation of cell growth
|
GO:0001558 |
91 |
0.018
|
Rat |
|
response to molecule of bacterial origin
|
GO:0002237 |
143 |
0.018
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.018
|
|